BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31465459)

  • 1. The Accuracy of Histopathological and Cytopathological Techniques in the Identification of the Mycetoma Causative Agents.
    Siddig EE; Mhmoud NA; Bakhiet SM; Abdallah OB; Mekki SO; El Dawi NI; Van de Sande W; Fahal AH
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007056. PubMed ID: 31465459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycetoma: reviewing a neglected disease.
    Verma P; Jha A
    Clin Exp Dermatol; 2019 Mar; 44(2):123-129. PubMed ID: 29808607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Isothermal Amplification Techniques for Identification of Madurella mycetomatis, the Prevalent Agent of Human Mycetoma.
    Ahmed SA; van de Sande WW; Desnos-Ollivier M; Fahal AH; Mhmoud NA; de Hoog GS
    J Clin Microbiol; 2015 Oct; 53(10):3280-5. PubMed ID: 26246484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study.
    Khatri ML; Al-Halali HM; Fouad Khalid M; Saif SA; Vyas MC
    Int J Dermatol; 2002 Sep; 41(9):586-93. PubMed ID: 12358829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genus Madurella: Molecular identification and epidemiology in Sudan.
    Ahmed EA; Nour BYM; Abakar AD; Hamid S; Mohamadani AA; Daffalla M; Mahmoud M; Altayb HN; Desnos-Ollivier M; de Hoog S; Ahmed SA
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008420. PubMed ID: 32730340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive complicated secondary inguinal mycetoma: a case series.
    Ezaldeen EA; Ahmed ES; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):420-425. PubMed ID: 33476389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.
    Verwer PE; Notenboom CC; Eadie K; Fahal AH; Verbrugh HA; van de Sande WW
    PLoS Negl Trop Dis; 2015; 9(9):e0004061. PubMed ID: 26332238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
    Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the performance of the common used eumycetoma diagnostic tests.
    Siddig EE; Nyuykonge B; Mhmoud NA; Abdallah OB; Bahar MEN; Ahmed ES; Nyaoke B; Zijlstra EE; Verbon A; Bakhiet SM; Fahal AH; van de Sande WWJ
    Mycoses; 2023 May; 66(5):420-429. PubMed ID: 36583225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
    Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
    Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mycetoma: 130 cases].
    Dieng MT; Sy MH; Diop BM; Niang SO; Ndiaye B
    Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):16-9. PubMed ID: 12605151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycetoma in Saudi Arabia.
    Bendl BJ; Mackey D; Al-Saati F; Sheth KV; Ofole SN; Bailey TM
    J Trop Med Hyg; 1987 Apr; 90(2):51-9. PubMed ID: 3550122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck mycetoma: Clinical findings, investigations, and predictors for recurrence of the disease in Sudan: A retrospective study.
    Omer AT; Hasabo EA; Bashir SN; El Hag NE; Ahmed YS; Abdelgadir II; Osman AA
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010838. PubMed ID: 36251632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycetomas in northern Yemen: identification of causative organisms and epidemiologic considerations.
    Yu AM; Zhao S; Nie LY
    Am J Trop Med Hyg; 1993 Jun; 48(6):812-7. PubMed ID: 8333574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The developed molecular biological identification tools for mycetoma causative agents: An update.
    Siddig EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Acta Trop; 2022 Jan; 225():106205. PubMed ID: 34687643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in culture-negative cases of Madurella mycetomatis: A case report re-accentuating PCR as an essential diagnostic tool.
    K S; Das S; Pandhi D; Rai G; Ansari MA; Gupta C; Haque S; Dar SA
    J Mycol Med; 2017 Dec; 27(4):577-581. PubMed ID: 29102309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Madurella mycetomatis infection of the buttock in an Eritrean refugee in Switzerland: a case report.
    Mekoguem C; Triboulet C; Gouveia A
    J Med Case Rep; 2019 Feb; 13(1):32. PubMed ID: 30755254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tropical diabetic foot.
    Henckaerts L; Naesens R; Vlieghe E; Jansens H; Gielen J; Ieven M; Moorkens G
    Acta Clin Belg; 2012; 67(5):362-4. PubMed ID: 23189544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region.
    Karrakchou B; Boubnane I; Senouci K; Hassam B
    BMC Dermatol; 2020 Jan; 20(1):1. PubMed ID: 31918687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [63 cases of mycetoma in the Niger Republic (etiological study based on histopathology)].
    Develoux M; Vetter JM; Audoin J; Treguer J
    Bull Soc Pathol Exot Filiales; 1985; 78(5):574-84. PubMed ID: 4085097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.